FBIA Comments on FDA Proposed Rule to Revoke Methods of Analysis Regulation
ASTA signed onto a coalition comment letter to the Food and Drug Administration(FDA) in September 2022 on the U.S. Food and Drug Administration (FDA or agency) proposed rule, Revocation of Methods of Analysis Regulation, revoking the methods of analysis regulation, § 2.19 (21 CFR 2.19), which describes an FDA policy to use certain methods of analysis to support FDA enforcement, as needed, and when the method of analysis is not prescribed in a regulation.
09/26/2022 at 5:15 am
2
Related Resources
ASTA Comments on FSMA Supplier Verification Guidance
ASTA issued comments to the Food and Drug Administration (FDA) in May 2018 on "Hazard Analysis and Risk-Based Preventive Controls for Human Food; Draft Guidance for Industry" and "Foreign Supplier Verification Programs for Importers of Food for Humans and Animals; Draft Guidance for Industry."
ASTA Comments on FDA's Proposed High-Risk Designation for Tracing
ASTA issued a comment to the Food and Drug Administration (FDA) in May 2014 regarding the designation of high-risk foods for tracing in response to the request for information and scientific data on the FDA's draft model for designating high-risk foods for tracing as part of its implementation of Section 204 of the FSMA.